Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

ReplyLetter

Reply:

R.K. Gupta
American Journal of Neuroradiology September 2010, 31 (8) E68; DOI: https://doi.org/10.3174/ajnr.A2174

We greatly appreciate the interest shown by Kapsalaki and Fountas regarding our recent article “In Vivo Proton MR Spectroscopy Evaluation of Pyogenic Brain Abscesses: A Report of 194 Cases.”1 We will try to address the concerns raised by the authors about this study.

It is usually not possible to differentiate cystic intracranial mass lesions on conventional MR imaging. We have shown in our previous studies the sensitivity and specificity of proton MR (1H-MR) spectroscopy in the differentiation of cystic intracranial lesions,2–4 and we did not attempt to differentiate these abscesses from other cystic lesions by using conventional MR imaging. We have previously reported the role of 1H-MR spectroscopy in the etiologic characterization of the pyogenic brain abscess.5 The purpose of this study was to look for the sensitivity and specificity of the commonly encountered metabolites in the etiologic characterization of brain abscess. We restricted our discussion to only pyogenic abscess and 1H-MR spectroscopy. Kapsalaki and Fountas mention that the absence of amino acids seen in our study does not rule out the nonpyogenic etiology. However, we would like to reiterate that the absence of amino acids does not rule out a pyogenic etiology.1 Diagnosis of the brain abscess was based on the culture of the microbes on aspiration, excision, and repeated aspiration and follow-up on antibiotic therapy. In this study, 56% of the patients with brain abscess had taken antibiotics for a variable period before 1H-MR spectroscopy, and some of these abscesses were sterile on culture. We have already reported the effect of antibiotic therapy on the metabolite pattern in pyogenic abscesses.6 Most patients underwent surgical intervention within 24 hours of the MR imaging. Of 194 cases included in our study, 55 patients had lipids along with lactate, while 11 had only lipids. The spectroscopy data were analyzed by 2 neuroradiologists who were blinded to the microbial culture data, with no significant interobserver variation.

References

  1. 1.
    1. Pal D,
    2. Bhattacharyya A,
    3. Husain M,
    4. et al
    . In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol 2010;31:360–66. Epub 2009 Oct 1
  2. 2.
    1. Poptani H,
    2. Gupta RK,
    3. Jain VK,
    4. et al
    . Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging 1995;13:1019–29
  3. 3.
    1. Shukla DA,
    2. Gupta RK,
    3. Roy R,
    4. et al
    . Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar-appearing intracranial cystic lesions. Magn Reson Imaging 2001;19:103–10
  4. 4.
    1. Mishra AM,
    2. Gupta RK,
    3. Jaggi RS,
    4. et al
    . Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assisted Tomogr 2004;28:540–47
  5. 5.
    1. Garg M,
    2. Gupta RK,
    3. Husain M,
    4. et al
    . Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 2004;230:519–27
  6. 6.
    1. Dev R,
    2. Gupta RK,
    3. Poptani H,
    4. et al
    . Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses. Neurosurgery 1998;42:37–43
Advertisement